Combination of the PLK1 Inhibitor Onvansertib and the PI3Ka Inhibitor Alpelisib Overcomes Palbociclib Resistance in PIK3CA-mutated HR+ Breast Cancer.
Alpelisib;Onvansertib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Combination of the PLK1 Inhibitor Onvansertib and the PI3Ka Inhibitor Alpelisib Overcomes Palbociclib Resistance in PIK3CA-mutated HR+ Breast Cancer. ### Output: Alpelisib;Onvansertib